English  |  正體中文  |  简体中文  |  Total items :2854037  
Visitors :  45440761    Online Users :  1531
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

Jump to a point in the index:
Or type in a year:
Show Most Recent First Ordering With Oldest First

Showing items 2235491-2235515 of 2346973  (93879 Page(s) Totally)
<< < 89415 89416 89417 89418 89419 89420 89421 89422 89423 89424 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-04T06:11:30Z Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavir Chen G.-Y.; Su T.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:30Z Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection Cheng H.-R.; JIA-HORNG KAO; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-09-04T06:11:31Z On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy Huang Y.-W.; Takahashi S.; Tsuge M.; Chen C.-L.; Wang T.-C.; Abe H.; Hu J.-T.; Chen D.-S.; Yang S.-S.; Chayama K.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:31Z Perspectives and control of hepatitis B virus infection in Taiwan Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:31Z Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients Wang C.-C.; Liu C.-H.; Lin C.-L.; Wang P.-C.; Tseng T.-C.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:32Z Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B Lin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; Su T.-H.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:32Z Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan Chen C.-L.; Yang J.-Y.; Lin S.-F.; Sun C.-A.; Bai C.-H.; You S.-L.; Chen C.-J.; JIA-HORNG KAO; Chen P.-J.; Chen D.-S.
臺大學術典藏 2021-09-04T06:11:33Z Hepatitis B virus genotypes and variants Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:33Z Hepatitis B vaccination and prevention of hepatocellular carcinoma JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:33Z Reimbursement policies in the Asia-Pacific for chronic hepatitis B Lim S.G.; Amarapurkar D.N.; Chan H.L.-Y.; Crawford D.H.; Gane E.J.; Han K.-H.; Ahn S.H.; Jafri W.; Jia J.; JIA-HORNG KAO; Lesmana L.A.; Lesmana C.R.A.; Mohamed R.; Phiet P.H.; Piratvisuth T.; Sarin S.K.; Sollarno J.D.; Eguchi Y.; Mahtab M.-A.; Lee K.H.
臺大學術典藏 2021-09-04T06:11:34Z Viral hepatitis: HBV cure-can we pin our hopes on immunotherapy? Yang H.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:34Z Treating immune-tolerant Hepatitis B Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:34Z Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages Liu C.-J.; Chen T.-C.; Chen P.-J.; Wang H.-Y.; Tseng T.-C.; Cheng H.-R.; Liu C.-H.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:35Z What can we learn from hepatitis B virus clinical cohorts? Lin C.-L.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:35Z Hepatitis B virus infection and metabolic syndrome: Fact or fiction? Wang C.-C.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:35Z Asunaprevir-containing regimens for the treatment of hepatitis C virus infection Yang S.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:36Z Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: Molecular mechanisms and clinical significance Yang H.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:36Z Risk stratification of HBV infection in Asia-Pacific region JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:36Z The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo Lin S.-R.; Yang H.-C.; Kuo Y.-T.; Liu C.-J.; Yang T.-Y.; Sung K.-C.; Lin Y.-Y.; Wang H.-Y.; Wang C.-C.; Shen Y.-C.; Wu F.-Y.; JIA-HORNG KAO; Chen D.-S.; Chen P.-J.
臺大學術典藏 2021-09-04T06:11:37Z Molecular mechanism and treatment of viral hepatitis-related liver fibrosis Su T.-H.; JIA-HORNG KAO; Liu C.-J.
臺大學術典藏 2021-09-04T06:11:37Z Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: Optimizing use of peginterferon alfa Liu C.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:37Z Triple therapy for hepatitis C virus infection in patients receiving hemodialysis Liu C.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:38Z HBeAg-positive chronic hepatitis B: Why do I treat my patients with pegylated interferon? JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:38Z A pilot study of add-on oral hypoglycemic agents in treatment-na?ve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin Hsu C.-S.; Hsu S.-J.; Lin H.H.; Tseng T.-C.; Wang C.-C.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:38Z Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients Wang C.-C.; Tseng T.-C.; Wang P.-C.; Lin H.H.; JIA-HORNG KAO

Showing items 2235491-2235515 of 2346973  (93879 Page(s) Totally)
<< < 89415 89416 89417 89418 89419 89420 89421 89422 89423 89424 > >>
View [10|25|50] records per page